Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines

BACKGROUND: Compound Kushen injection (CKI) is a commonly used anti-tumor Chinese patent medicine, which is extracted from Kushen (Radix Sophorae Flavescentis) and Baituling (Rhizoma Smilacis Glabrae) and has been widely prescribed as an add-on therapy to platinum-based chemotherapy (PBC) for advanc...

詳細記述

保存先:
書誌詳細
出版年:Medicine (Baltimore)
主要な著者: Chen, Hongwei, Yao, Xiaojun, Li, Ting, Lam, Christopher Wai-Kei, Zhang, Huixia, Wang, Jue, Zhang, Wei, Leung, Elaine Lai-Han, Wu, Qibiao
フォーマット: Artigo
言語:Inglês
出版事項: Wolters Kluwer Health 2019
主題:
3800
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946292/
https://ncbi.nlm.nih.gov/pubmed/31876753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018552
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料